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INTRODUCTION
Gastric carcinoma (GC) is one of the major causes of 
mortality and morbidity worldwide (1) and it is also one 
of the leading causes of death worldwide (2). GC prog-
nosis remains poor as it is rarely detected early, and the 
majority of cases show distant metastasis at the time of 
diagnosis (3,4). Developing countries account for two-
thirds of the reported incidences of GC worldwide (5). 
The incidence of GC in both men and women is con-
centrated primarily in Asia, and the highest incidence 
has been reported in Asian countries e.g. Japan, China 
and Korea (6,7).
Helicobacter pylori (H. pylori) is a major cause of gastro-
duodenal ulcer and risk factor for GC and lymphoma. 
In developing countries located in Asia e.g., Pakistan 
and India, H. pylori infection is frequent in the general 
population and occurs at an early age. In our country, H. 
pylori is acquired at an early age and H.pylori seroposi-
tivity in children (11-15 years old) is 53.5% (8). In con-
trast, in developed Asian countries like Japan and Sin-
gapore, the frequency of H. pylori infection is reported 
to be somewhat lower (9,10). In the United States, the 
prevalence of H. pylori has decreased to approximately 
10% in the white middle and upper class populations 
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ABSTRACT
Background/Aims: South Asia is an enigma for gastric cancer (GC) because it is a low risk region with a high 
prevalence of Helicobacter pylori (H. pylori) infections. We evaluated the trend of GC clinical presentation and risk 
factors in patients with dyspeptic symptoms. 
Materials and Methods: The medical records of patients, coded by the international classification of diseases 
(ICD-10-CM, 2015, Diagnosis Code C16.9) for malignancies of stomach diagnosed by esophagogastroduode-
noscopy (EGD) and histopathology, were studied.
Results: 394 GC cases with a mean age of 54±15 years, range of 18 to 88, were analyzed. 256 (65%) were male. 
Distal non-cardiac and cardiac tumors were 302 (77%) and 92 (23%) cases, respectively. The WHO classification 
of GC defined 222 (56%) cases as intestinal type adenocarcinoma, 68 (17%) cases as signet ring cell carcinoma 
(SRC), 62 (16%) cases as diffuse type and 42 (11%) cases as B cell non-Hodgkin lymphoma. The co-morbid con-
ditions associated with GC were H. pylori infection (positive in 246 (62%) cases), diabetes mellitus type 2 (in 90 
(23%) cases), and cigarette smoking (in 94 (24%) cases). Of the male patients, 88 (34%) (p<0.001) were smokers. 
Body mass index was abnormal in all age groups and in both sexes. Cardiac regions for GC were more common 
in the 46- to 60-year old age range and in males. Diffuse GC was seen in all age groups but there were signifi-
cantly more common in the 18- to 45-year old age range. Gastric non-Hodgkin’s lymphoma was seen at an early 
age of 18-45 years in 14(12%) and a later of 61-88 years in 20 (15%).
Conclusion: Intestinal type GC is common at all ages but SRC and diffuse GC are more common in patients less 
than 50 years old. SRC and diffuse GC were not specific to the elderly in our study population.
Keywords: Gastric carcinoma, male, age, H. pylori, noncardiac, intestinal type carcinoma, signet cell carcinoma 
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younger than 50 years old (11). H. pylori is transmitted by the 
feco-oral route. It is associated with areas of overcrowding, 
poor sanitation, lower socioeconomic status, and poor water 
supply because these are risk factors for H. pylori infection. As a 
result, there is a higher frequency and lower age of acquisition 
for H. pylori in less developed Asian countries (12,13). In Paki-
stan, there is a high prevalence of H. pylori, but the prevalence 
of GC is low. This study determined the distribution of GC in our 
patients with upper gastrointestinal symptoms and risk factors 
associated with GC.
MATERIALS AND METHODS
In this cross-sectional study, the medical records of patients 
aged 18 years and over who attended the hospital were re-
viewed. These patients presented with pain, nausea or vom-
iting, weight loss, hematemesis, melena, and had an esopha-
gogastroduodenoscopy (EGD) between January 2000 and 
January 2016. The “gastric carcinoma cases” were defined as pa-
tients who fulfill the 2015 ICD-10-CM Diagnosis Code C16.9 for 
malignancies of the stomach. Three hundred and ninety-four 
patients fulfilled these criteria. The demographic characteristics 
that were taken into account included: mean age, sex, address 
of permanent residence, body weight (kg), height (cm), symp-
toms, use of medications [analgesics, proton pump inhibitors 
(PPIs), etc.], diagnosis, blood glucose levels, lipid profile, hemo-
globin levels, hemoglobinA1c levels, liver function test, com-
plete blood count, H. pylori serology, (14) carbon labeled-urea 
breath test (14C-UBT) or stool antigen test (HpSA), and tumor 
markers [protein CA 125 (cancer antigen 125) and carcinoma 
embryonic antigen (CEA)] were recorded. Cigarette smoking, 
alcohol intake, and occupational history were also noted.
Study Design
This was a cross sectional study.
Setting 
Retrospective data collection from patient medical records was 
performed after obtaining approval by the institutional ethics 
review committee.
Inclusion Criteria
All patients, irrespective of sex, age, and ethnic background, 
that presented with upper gastrointestinal symptoms and 
diagnosed as having GC between January 2000 and January 
2016 were included.
Exclusion Criteria
Individuals with a history of gastrectomy for GC, aplastic ane-
mia, scleroderma, gastric lymphoma, and gastrointestinal stro-
mal tumor (GIST) were excluded.
Endoscopy
The morphology of GC was described as exophytic, ulcerated, 
infiltrative, or combined. Bormann’s classification described the 
appearance of GC as type I for polypoid growth, type II for fun-
gating growth, type III for ulcerating growth, and type IV for 
diffusely infiltrating growth (linitis plastica in SRC).
Esophageal carcinoma anatomic classification was if its epicen-
ter was in the lower thoracic esophagus or gastroesophageal 
junction (GEJ) or within the proximal 5 cm of stomach (i.e., car-
dia) with the tumor mass extending into GEJ or distal esopha-
gus. If the origin was >5 cm distal to the GEJ, or within 5 cm of 
GEJ but did not extend into GEJ or esophagus, it was grouped 
as GC (14).
Histopathology 
At the time of endoscopy, at least 2 or more biopsies were ob-
tained from gastric abnormalities with standard biopsy forceps 
and tissues were submitted for histopathological examination. 
Specimens were fixed overnight in 10% buffered formalin and 
gross examination performed the next day was followed by 
paraffin embedding. Slides were stained with hematoxylin and 
eosin. The reporting (according to the TNM staging system) in-
corporated gross examination, tumor location, type and grade, 
depth of invasion, surgical resection margins, and lymph node 
status. Histological classification of GC was based on Lauren’s 
criteria (15).
Statistical Analysis
Results were expressed as mean±standard deviation. Uni-
variate analysis was performed using an independent sample 
t-test, Pearson Chi-square test or Fisher Exact test where ap-
plicable. A p value <0.05 was considered significant. Statisti-
cal interpretation of data was performed using IBM Statistical 
Package for the Social Sciences Statistics (IMB SPSS Statistics; 
Armonk, NY, USA) version 19.0.
Technique
The technique used was non-probability consecutive sampling.
Data Collection Procedure
Exemption from the institutional ethics review committee 
(ERC) was obtained. All pathologically documented gastric 
cancer records during a 16-year period (from 2000 to 2016) 
were recorded. Cases of GC presenting for the first time during 
the 16- year period were identified. All demographic, clinical, 
and endoscopic data from each patient were gathered and 
analyzed. 
RESULTS
There were 394 cases. The mean age was 53±15 (range: 18-88) 
years of age. Male patients constituted 256 (65%) cases and 
138 (35%) cases were female patients. 
Risk Factors
There was no difference in the distribution of H. pylori infection in 
patients in relation to age, sex, and site of malignancy (Table 1, 2). 
The co-morbid conditions associated with GC were diabe-
tes mellitus type 2 in 90 (23%) case, essential hypertension in 
99
Yakoob et al. Gastric carcinoma and high prevalence of H. pyloriTurk J Gastroenterol 2017; 28: 98-103
O
ri
gi
na
l A
rt
ic
le
68 (23%) cases, and cigarette smoking in 94 (24%) cases. The 
distribution of GC was not related to the history of smoking. 
However, male patients [88 (34%) cases (p<0.001)] were more 
commonly smokers than female patients [6 (4%) cases] (Table 
2). Body mass index was noted to be abnormal in all the age 
groups and in both sexes (Table 2).
Gastric Tumors
Gastric carcinoma arising from the non-cardiac region of the 
stomach was equally common in all age groups (Table 2). 
However, cardiac region tumors were more common in 46- to 
60-year old patients and in males (Table 2). GC arising in the 
antrum were common in the 18 to 45-year old age group [68 
(60%) cases (p=0.196)], but they were equally common in the 
two other age groups (Table 2). GC arising from the gastric 
lesser curve were more common in male patients compared 
to female patients and in the 46- to 60-year old age group 
[38 (25%) cases (p=0.006)] compared to the other age groups 
(Table 2). Diffuse GC was seen in all three age groups, but they 
were significantly more common in the younger age group 
(18- to 45-year old) and did not show any sex-related distribu-
tion (Table 2). Intestinal type GC was found equally in all age 
groups and also did not show any sex-related distribution (Ta-
ble 2). GC, fungoid in shape in 36 (28%) cases, was significantly 
more common in the 61- to 88-year old age group than in the 
younger age groups (Table 2). SRCs were found frequently in 
the 18 to 45-year old and 46- to 60-year old age groups (Table 
2). Gastric non-Hodgkin’s lymphoma was not associated with 
sex and demonstrated two peaks in our patients: 14 (12%) 
cases in the 18- to 45-year old group and 20 (15%) cases in the 
61- to 88-year old group (Table 2). 
Gastric Metastases
Lymph node metastases were equally common in all age 
groups and marginally more common in female patients than 
male 98 (71%) vs. 156 (61%) (p=0.046), respectively (Table 2). 
Liver metastases were common in the older age group and oc-
curred equally in both sexes (Table 2). Pulmonary metastases 
were also significantly more common in the older age group 
and in female patients [32 (23%) cases (p<0.001)] compared to 
male patients (26 (10%) cases) (Table 2). Peritoneal metastases 
were common in the 18- to 45-year old age group compared 
to the older age groups, and also significantly more common 
in females [32 (23%) cases (p<0.001)] compared to males [26 
(10%) cases] (Table 2).
DISCUSSION
Gastric carcinomas were twice more common in males than 
in females. Only 32% of the GC cases were seen in elderly pa-
tients (61- to 88-year old age group). The study did not show a 
significant distribution in the elderly population as our patients 
with GC had a median age of 55 years. This is different from GC 
prevalence in other populations where GC is usually observed 
in patients 70 and older (16). Among the risk factors for GC, the 
H. pylori infection factor did not vary in the different age groups 
nor demonstrated a sex distribution (Table 2). H. pylori infection 
diagnoses involved in these cases was biopsy obtained at en-
doscopy for histology and did not include usage of a 14C-UBT 
or HpSA test, which are better diagnostic tests (17). In practice, 
the H. pylori treatment prescribed is not based on local H. py-
lori antibiotic sensitivities. Post-treatment of H. pylori infection, 
there was an absence of documentation regarding eradication 
of the infection. 
Smoking was common in all age groups, particularly in male 
patients (Table 2). This is in keeping with our National Health 
Survey, which described 46% men and 5.7% women as smok-
ing tobacco (contributing to 80,000 deaths annually) (18). A 
cross sectional survey in a tertiary care center revealed that 
39% of patients aged 18 years or older had either hypertension 
Age (year) mean±SD 54±15
Range 18-88
Sex 
Male/Female 256/138
Symptoms n (%)
Weight loss 290 (74)
Nausea 232 (59)
Loss of appetite 216 (55)
Epigastric pain 184 (53)
Dysphagia 114 (29)
Melena 66 (17)
Constipation 68 (17)
Gastric outlet obstruction 54 (14)
Hematemesis 48 (12)
Endoscopy features
Diffuse 224 (59)
Fungoid 76 (19)
Ulceration 66 (17)
Polypoid 18 (5)
Site of tumor 
Cardiac 92 (23)
Non-cardiac 302 (77)
Histology 
Intestinal type 222 (56)
Signet cell carcinoma 68 (17)
Diffuse 62 (16)
Lymphoma 42 (11)
Histology 
Well differentiated 74 (19)
Moderately differentiated 194 (49)
Poorly differentiated 126 (32)
Risk factors 
Helicobacter pylori 246 (62)
Cigarette smoker 94 (24)
Alcohol 12 (3)
Metastases  
Lymph nodes 228 (60)
Peritoneum 64 (16)
Liver 48 (13)
Pulmonary 38 (11)
Bone 8 (2)
Small intestine 4 (1)
Pancreas 4 (1)
Table 1. Clinical details of the patients with gastric carcinoma (n=394)
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  Age   Sex 
 Group I Group II Group II 
 (18- to 45-year olds) (46- to 60-year olds) (61- to 88- year olds)  Male Female 
 n=114 n=152 n=128 p n=256 n=138 p
Site        
Cardia       
Yes 18 (16) 48 (32) 26 (22) 0.007 70 (27) 22 (16) 0.011*
No 96 (84) 104 (68) 102 (78)  186 (73) 116 (84)
Fundus       
Yes 20 (18) 36 (24) 40 (31) 0.045 68 (27) 28 (20) .166
No 94 (82) 116 (76) 88 (69)  188 (73) 110 (80) 
Corpus       
Yes 38 (33) 52 (34) 46 (36) 0.909 80 (31) 56 (41) 0.063
No 76 (67) 100 (66) 82 (64)  176 (69) 82 (59) 
Antrum       
Yes 68 (60) 74 (49) 66 (52) 0.196 128 (50) 80 (58) 0.131
No 46 (40) 78 (51) 62 (48)  128 (50) 58 (42) 
Lesser curve       
Yes 14 (12) 38 (25) 16 (12) 0.006 56 (22) 12 (9) 0.001
No 100 (88) 114 (75) 112 (88)  200 (78) 126 (91) 
Greater curve       
Yes 8 (7) 14 (9) 16 (13) 0.344 28 (11) 10 (7) 0.236
No 106 (93) 138 (91) 112 (87)  228 (89) 128 (93) 
Boremann classification       
Polypoid 4 (3) 6 (4) 8 (6) 0.001 16 (6) 2 (1) 0.070
Fungoid 12 (10) 28 (18) 36 (28)  46 (18) 30 (22) 
Ulcerating 18 (16) 20 (13) 28 (22)  46 (18) 20 (15) 
Diffuse  110 (72) 98 (65) 56 (44)  148 (58) 86 (62) 
WHO GCa Classification        
Adenocarcinoma       
Intestinal type 34 (30) 54 (37) 48 (38)  96 (38) 40 (29) 
Papillary 0 (0) 0 (0) 2 (2)  2 (1) 0 (0) 
Mucinous 0 (0) 6 (4) 4 (3)  10 (4) 0 (0) 
Signet ring cell 26 (23) 32 (21) 10 (8)  38 (15) 30 (22) 
Adenoosquamous 4 (3) 4 (2) 0 (0) <0.001 4 (2) 4 (3) 0.022
Diffuse 36 (32) 42 (27) 34 (26)  70 (27) 42 (30) 
GI stromal tumor 0 (0) 2 (1) 4 (3)  4 (2) 2 (1) 
Lymphoma 14 (12) 8 (5) 20 (15)  24 (9) 18 (13) 
Metastatic carcinoma 0 (0) 4 (3) 6 (5)  8 (3) 2 (1%) 
Metastases       
Lymph nodes        
Yes 84 (74) 98 (64) 72 (56) 0.018 156 (61) 98 (71) 0.046
No 30 (26) 54 (36) 56 (44)  100 (39) 40 (29) 
Liver       
Yes 4 (4) 20 (13) 18 (14) 0.005 32 (12) 10 (7) 0.107
No 110 (96) 132 (87) 110 (86)  224 (88) 128 (93) 
Pulmonary       
Yes 4 (4) 20 (13) 20 (16) 0.003 26 (10) 32 (23) <0.001
No 110 (96) 132 (87) 108 (84)  230 (90) 106 (77) 
Peritoneal       
Yes 24 (21) 20 (13) 14 (11) 0.067 26 (10) 32 (23) <0.001
No 90 (79) 132 (87) 114 (89)  230 (90) 106 (77) 
Risk factors        
Cigarette smoker       
Yes 24 (21) 36 (24) 34 (27) 0.603 88 (34) 6 (4) <0.001
No 90 (79) 116 (76) 94 (73)  168 (66) 132 (96) 
Body mass index (BMI)       
Healthy<23 8 (7) 2 (1) 4 (3) 0.047 2 (1) 12 (8) <0.001
Over weight>23 106 (93) 150 (99) 124 (97)  254 (99) 126 (91) 
Helicobacter pylori       
Positive 68 (60) 92 (60) 86 (67) 0.397 160 (63) 86 (62) 0.972
Negative 46 (40) 60 (40) 42 (33)  96 (37) 52 (38) 
Diabetes mellitus       
Positive 18 (16) 30 (20) 42 (33) 0.004 56 (22) 34 (25) 0.533
Negative 96 (84) 122 (80) 86 (67)  200 (78) 104 (75)
Table 2. Association of gastric carcinoma with age and sex
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or dyslipidemias with a history of active smoking (19). Based on 
the data of the National Health Survey, the overall prevalence 
of smoking among 15-year olds or older was 15.2% and the 
prevalence of smoking was 28.6% in men compared to 3.4% in 
women (20). The incidence of GC in male patients was in keep-
ing with the prevalence of smoking in the male population. In-
creased salt intake has been described as an independent risk 
factor of GC. In a population based study, an increased dietary 
salt intake was documented among different communities in 
Karachi (21). Furthermore, according to the National Health 
Survey, 25.0% of the population was overweight or obese (22). 
The majority of patients with GC had a BMI that was deemed 
“overweight” in the majority of our GC patients, regardless of 
age or sex (Table 2). This is in agreement with the high BMI that 
was associated with the distribution of GC. Diabetes mellitus 
type 2 was significantly associated with GC in all age groups 
with a marked distribution in the 61- to 88-year old group [33% 
(p=0.004)] (Table 2). This is in keeping with the high prevalence 
of diabetes mellitus in this age group (equal sex distribution). 
According to the 2011 figure of the World Health Organization, 
the prevalence of diabetes mellitus in our population was the 
7th highest in the world at 12.9%, which is the 10% of our popu-
lation (23). 
The gastric rich lymphatic and vascular supply explained ex-
tensive lymph node and liver metastases in GC at presenta-
tion. Lymph nodes metastases were equally common in all 
age groups regardless of sex. However, they were more com-
mon in the early age group of 18- to 45-year olds (84 (74%) 
cases) compared the older age group of 61- to 88-year olds (72 
(56%) cases) (Table 2). At presentation, liver metastases were 
common in the two older age groups (Table 2). Pulmonary 
metastases [32 (23%) cases (p<0.001)] were more common in 
female compared to male (26 (10%) cases) patients. In previ-
ous studies, diffuse GC was found commonly in young female 
patients (24,25) while intestinal GC (associated with intestinal 
metaplasia) and H. pylori infection was found equally in all age 
groups (25,26). In an earlier local study, 53% of GC cases were 
located in the gastric antrum and 35% in the proximal part (27). 
However in the present study, distal gastric tumors and cardiac 
tumors were 77% and 23%, respectively (Table 1). 
The implications of this study is that the education of the pop-
ulation at large and effective treatment of the risk factors of GC 
should be offered to the patients. In the absence of effective 
screening for early diagnosis of GC, we will continue to see pa-
tients with extensive disease progression at presentation.
Gastric carcinoma incidence has decreased in industrialized 
countries. GC is still a cause of mortality and morbidity in de-
veloping countries. A non-cardiac predominant disease was 
shown here to be associated with H. pylori infection and will 
require more effective management and eradication. In con-
clusion, GC is not an elderly disease in our population, which is 
different from developed countries.
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